Obagi Medical Products (OMPI) Inactive 10-Q2010 Q2 Quarterly report

Filed: 9 Aug 10, 12:00am

Content analysis

Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability	8th grade Good

New words: abandoned, Additionally, addressing, Agency, agreed, applicationin, Asia, assumption, aunched, Avon, bad, breadth, bring, Canada, cap, capable, categor, cease, center, Chem, chemical, complimentary, comply, composed, compromised, conduct, conducted, confirm, conflict, convicted, coordinating, core, crime, cultural, customary, de, ded, delineated, denying, Department, detailed, deve, disagree, Disco, Discovery, disgrace, disrepute, dissolution, dissolved, distract, diversified, divert, documented, dormant, eighteen, eliminated, en, enjoin, eral, exclusive, exploit, exploiting, exploring, external, fact, factual, fail, fall, fee, felony, ft, fully, gain, gro, Guide, healthcare, hired, honor, hreatening, ient, imarily, import, important, imported, incremental, infringement, institute, invalid, Jose, JR, lawsuit, letter, leverage, licensee, licenso, licensor, life, llion, lop, lose, marketi, matter, maturing, ment, Mexico, mi, minimal, minimum, mirror, misconduct, modified, modify, modifying, ng, nonfeasance, notice, notified, notify, notifying, onsisting, operationally, opposed, opposition, original, owed, pat, pending, Policy, political, portfolio, pr, preclude, presence, pri, principle, priority, project, prosecuting, Pte, purportedly, Ramirez, rapid, reach, reached, refusal, renegotiate, renewed, resolve, restoration, resul, rms, rs, schedule, scientific, scribe, se, set, settlement, sha, Singapore, slightly, Southeast, standing, sublicense, subsidiary, successful, survive, target, tariff, te, thereto, tho, tiered, ting, trade, ulting, unapproved, undergoing, unexpected, unfounded, unreasonably, unresolved, unrest, valid, validity, variety, vent, viii, virtue, widely, withheld, world, worldwide, written, wth

Removed: deduction, deficiency, deficient, discontinued, hypothetical, insufficient, length, mix, operational, oriented, prepaid, return, stocking, yielding

Search this filing

Filing tables

Export all tables to Excel

Filing exhibits

Related press release

OMPI similar filings

Filing view

Default size S M L
Default font Times Arial

External links

Share this filing

Exhibit 32.1

Obagi Medical Products, Inc.

CERTIFICATION OF THE CHIEF EXECUTIVE OFFICER

PURSUANT TO

18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report on Form 10-Q of Obagi Medical Products, Inc. (the "Company") for the three and six months ended June 30, 2010, as filed with the Securities and Exchange Commission on the date hereof (the "Report"), I, Steven R. Carlson, Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:

(1) The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.



Date: August 9, 2010	By:	/s/ STEVEN R. CARLSON
		Steven R. Carlson
		Chief Executive Officer
		(Principal Executive Officer)